These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6394865)

  • 1. [Basic principles of the current treatment of primary pulmonary hypertension].
    Konopleva LF; Revutskiĭ EL; Previr VN
    Kardiologiia; 1984 Oct; 24(10):121-5. PubMed ID: 6394865
    [No Abstract]   [Full Text] [Related]  

  • 2. Levosimendan and pulmonary hypertension.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract]   [Full Text] [Related]  

  • 3. Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):503-7. PubMed ID: 19346968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].
    Dubiel JP; Cibor E; Bieron K; Zmuda A; Kostka-Trabka E
    Kardiol Pol; 1988; 31(10):626-32. PubMed ID: 3253452
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandins in patients with pulmonary hypertension: the route of administration.
    Booke M; Van Aken H; Theilmeier G; Meyer J
    Anesth Analg; 1998 Apr; 86(4):917. PubMed ID: 9539630
    [No Abstract]   [Full Text] [Related]  

  • 6. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha blockade in pulmonary hypertension.
    Cottrell AJ; Pearson DT; Hunter S
    Pediatr Cardiol; 1982; 2(1):89-90. PubMed ID: 6460991
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension.
    Montani D; Savale L; Natali D; Jaïs X; Herve P; Garcia G; Humbert M; Simonneau G; Sitbon O
    Eur Heart J; 2010 Aug; 31(15):1898-907. PubMed ID: 20543192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery.
    Hirono K; Yoshimura N; Taguchi M; Watanabe K; Nakamura T; Ichida F; Miyawaki T
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):346-51. PubMed ID: 20434177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan and nifedipine therapy in patients with secondary pulmonary hypertension.
    Yilmaz R
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):50-1. PubMed ID: 20150005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypoxic pulmonary hypertension: modern views on pathogenesis and options for rational pharmacological correction].
    Strielkov IeV; Frantsuzova SB; Khromov OS
    Fiziol Zh (1994); 2012; 58(2):89-100. PubMed ID: 22873057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in 2012: contemporary issues in diagnosis and management.
    Lau EM; Corte TJ
    Panminerva Med; 2012 Mar; 54(1):11-28. PubMed ID: 22278113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
    J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary hypertension-"state of the art" management in 2012.
    Saxena A
    Indian Heart J; 2012; 64(1):60-73. PubMed ID: 22572428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic alterations in pulmonary artery pressure in the adult respiratory distress syndrome.
    Weigelt JA; Gewertz BL; Aurbakken CM; Snyder WH
    J Surg Res; 1982 Mar; 32(3):243-8. PubMed ID: 7070077
    [No Abstract]   [Full Text] [Related]  

  • 17. Building the case for novel clinical trials in pulmonary arterial hypertension.
    Ryan JJ; Rich JD; Maron BA
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):114-23. PubMed ID: 25604559
    [No Abstract]   [Full Text] [Related]  

  • 18. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
    Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
    Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin therapy for pulmonary arterial hypertension.
    Ruan CH; Dixon RA; Willerson JT; Ruan KH
    Tex Heart Inst J; 2010; 37(4):391-9. PubMed ID: 20844610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.